Sifting through countless of stocks in the Software industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in SentinelOne, Inc. or Cellebrite DI Ltd. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.
Read on to learn how SentinelOne, Inc. and Cellebrite DI Ltd. compare based on key financial metrics to determine which better meets your investment needs.
About SentinelOne, Inc. and Cellebrite DI Ltd.
SentinelOne, Inc. operates as a cybersecurity provider in the United States and internationally. The company’s Singularity Platform delivers an artificial intelligence-powered autonomous threat prevention, detection, and response capabilities across an organization’s endpoints, cloud workloads, and identify credentials, which enables seamless and autonomous protection against a spectrum of cyber threats. It also offers generative AI-security agent (Purple AI), security information and event management, endpoint security, cloud security, identity security, exposure and vulnerability management, and threat services. The company has a collaboration with Amazon Web Services (AWS) to deliver unified AI governance for customers building on Amazon Bedrock. The company was formerly known as Sentinel Labs, Inc. and changed its name to SentinelOne, Inc. in March 2021. SentinelOne, Inc. was incorporated in 2013 and is headquartered in Mountain View, California.
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
Latest Software and SentinelOne, Inc., Cellebrite DI Ltd. Stock News
As of August 21, 2026, SentinelOne, Inc. had a $7.3 billion market capitalization, compared to the Software median of $1.1 million. SentinelOne, Inc.’s stock is up 41.3% in 2026, down 8.3% in the previous five trading days and up 26.58% in the past year.
Currently, SentinelOne, Inc. does not have a price-earnings ratio. SentinelOne, Inc.’s trailing 12-month revenue is $1.0 billion with a -30.4% net profit margin. Year-over-year quarterly sales growth most recently was 20.8%. Analysts expect adjusted earnings to reach $0.348 per share for the current fiscal year. SentinelOne, Inc. does not currently pay a dividend.
As of August 21, 2026, Cellebrite DI Ltd. had a $2.8 billion market cap, putting it in the 58th percentile of all stocks. Cellebrite DI Ltd.’s stock is down 38.7% in 2026, down 0.8% in the previous five trading days and down 28.62% in the past year.
Currently, Cellebrite DI Ltd.’s price-earnings ratio is 48.0. Cellebrite DI Ltd.’s trailing 12-month revenue is $514.3 million with a 11.4% net profit margin. Year-over-year quarterly sales growth most recently was 37.0%. Analysts expect adjusted earnings to reach $0.549 per share for the current fiscal year. Cellebrite DI Ltd. does not currently pay a dividend.
How We Compare SentinelOne, Inc. and Cellebrite DI Ltd. Stock Grades
Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.
AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at SentinelOne, Inc. and Cellebrite DI Ltd.’s stock grades to see how they measure up against one another.
Learn more about A+ Investor here!
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
SentinelOne, Inc. and Cellebrite DI Ltd. Stock Value Grades
| Company | Ticker | Value |
| SentinelOne, Inc. | S | F |
| Cellebrite DI Ltd. | CLBT | F |
Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection.
Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.
AAII’s A+ Investor Value Grade derives from a stock’s value score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.
Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.
SentinelOne, Inc. has a Value Score of 8, which is Ultra Expensive.
Cellebrite DI Ltd. has a Value Score of 14, which is Ultra Expensive.
The Value Stock Winner: No Clear Winner
Neither SentinelOne, Inc. or Cellebrite DI Ltd. has a high enough value grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolio. It’s important to look at a wide range of financial metrics in order to determine if SentinelOne, Inc. or Cellebrite DI Ltd. is the better investment when it comes to value.
SentinelOne, Inc. and Cellebrite DI Ltd. Growth Grades
| Company | Ticker | Growth |
| SentinelOne, Inc. | S | D |
| Cellebrite DI Ltd. | CLBT | B |
The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.
In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.
The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.
SentinelOne, Inc. has a Growth Score of 32, which is Weak.
Cellebrite DI Ltd. has a Growth Score of 69, which is Strong.
The Growth Grade Winner: Cellebrite DI Ltd.
As you can clearly see from the Growth Grade breakdown above, Cellebrite DI Ltd. has a more attractive growth grade than SentinelOne, Inc.. For investors who focus solely on how a company is growing relative to other companies in the same industry, Cellebrite DI Ltd. could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.
SentinelOne, Inc. and Cellebrite DI Ltd.’s Estimate Revisions Grades
| Company | Ticker | Earnings Estimate |
| SentinelOne, Inc. | S | C |
| Cellebrite DI Ltd. | CLBT | D |
Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).
Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.
SentinelOne, Inc. has a Earnings Estimate Score of 53, which is Neutral.
Cellebrite DI Ltd. has a Earnings Estimate Score of 37, which is Negative.
The Earnings Estimate Revisions Stock Winner: No Clear Winner
Neither SentinelOne, Inc. or Cellebrite DI Ltd. has an Earnings Estimate Revisions Grade that could be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if SentinelOne, Inc. or Cellebrite DI Ltd. is the better investment when it comes to estimate revisions.
Don’t Forget Your Free Special Report on How A+ Grades Can Help You Make Investment Decisions
Other SentinelOne, Inc. and Cellebrite DI Ltd. Grades
In addition to Estimate Revisions, Growth and Value, A+ Investor also provides grades for Momentum and Quality.
Momentum grades help uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming.
AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.
These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether SentinelOne, Inc. and Cellebrite DI Ltd. pass any of our 60+ stock screens that have outperformed the market since their creation.
So, Which Is the Better Investment, SentinelOne, Inc. or Cellebrite DI Ltd. Stock?
Overall, SentinelOne, Inc. stock has a Value Score of 8, Growth Score of 32 and Estimate Revisions Score of 53.
Cellebrite DI Ltd. stock has a Value Score of 14, Growth Score of 69 and Estimate Revisions Score of 37.
Comparing SentinelOne, Inc. and Cellebrite DI Ltd.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.
Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.
A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.
AAII Disclaimer
We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.
Included With AAII Platinum
Screen: 23.7%
Annual Gain Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.